<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03692286</url>
  </required_header>
  <id_info>
    <org_study_id>ENDO18</org_study_id>
    <nct_id>NCT03692286</nct_id>
  </id_info>
  <brief_title>Assessment of Postoperative Pain After Using Various Intracanal Medication in Patients With Necrotic Pulp</brief_title>
  <official_title>Assessment of Postoperative Pain After Using Silver Nanoparticles With and Without Calcium Hydroxide as an Intracanal Medication in Patients With Necrotic Pulp: (A Randomized Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the Postoperative Pain after using Silver Nanoparticles with and without Calcium&#xD;
      Hydroxide as an Intracanal Medication in Patients with necrotic pulp (RCT)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When the treatment itself appears to initiate the onset of pain and/or swelling, the result&#xD;
      can be very distressing to both the patient and the operator. Patients might even consider&#xD;
      postoperative pain and flare-up as a benchmark against which the clinician's skills are&#xD;
      measured. Prevalence of postoperative pain or flare-up is, therefore, one of the influencing&#xD;
      factors when making a clinical decision. Better management of postoperative pain increases&#xD;
      the patients' confidence in dentist's skills and gives positive attitude toward dental&#xD;
      profession. In cases with necrotic pulp, the incidence of pain becomes higher, hence testing&#xD;
      which intracanal medication is more effective in decreasing the bacteria present within the&#xD;
      root canal and subsequently pain is crucial.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Actual">September 18, 2020</completion_date>
  <primary_completion_date type="Actual">August 18, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in post-operative pain</measure>
    <time_frame>Intra-appointment and post obturation at 4, 24, 48, 72, 96 hours</time_frame>
    <description>Numerical (0-10)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intracanal Bacterial count reduction</measure>
    <time_frame>1 week</time_frame>
    <description>Quantification of Colony forming units per milliliter of agar medium (CFU/mL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of analgesic tablets taken by the patient after endodontic treatment</measure>
    <time_frame>Within 4 days after the first session and after 1 week from first treatment session</time_frame>
    <description>Number</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>AgNP/Ca(OH)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receiving combined Silver nanoparticle/Calcium hydroxide administered as intracanal medication at the first visit after cleaning and shaping</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AgNP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receiving silver nanoparticles in gel form administered as intracanal medication at the first visit after cleaning and shaping</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ca(OH)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receiving calcium hydroxide intracanal medication at the first visit after cleaning and shaping</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Silver nanoparticle/Calcium hydroxide</intervention_name>
    <description>Intracanal Medication composed of combined silver nanoparticles with calcium hydroxide</description>
    <arm_group_label>AgNP/Ca(OH)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Silver Nanoparticles in gel form</intervention_name>
    <description>Intracanal medication composed of silver nanoparticles in gel form</description>
    <arm_group_label>AgNP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calcium Hydroxide Intracanal medication</intervention_name>
    <description>Calcium hydroxide intracanal medication</description>
    <arm_group_label>Ca(OH)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who are free from any physical or mental handicapping condition with no&#xD;
             underlying systemic disease.&#xD;
&#xD;
          -  Non-pregnant females&#xD;
&#xD;
          -  Asymptomatic necrotic mandibular single rooted teeth.&#xD;
&#xD;
          -  Normal occlusal contact with the opposing teeth.&#xD;
&#xD;
          -  Patients accepting to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Medically compromised patients: Pain levels and healing following treatment would be&#xD;
             compromised as these patients have shown higher incidence of pain and lower healing&#xD;
             rate.&#xD;
&#xD;
          -  Pregnant women: Avoid radiation exposure, anesthesia, and medication.&#xD;
&#xD;
          -  If analgesics or antibiotics have been administrated by the patient during the past 12&#xD;
             hours preoperatively might alter their pain perception&#xD;
&#xD;
          -  Patients reporting bruxism or clenching: Avoid further pressure on an already inflamed&#xD;
             tooth inducing subsequent irritation and inflammation Teeth that shows:&#xD;
&#xD;
          -  Association with acute periapical abscess and swelling: Need special treatment steps&#xD;
             which could involve additional visits with incision and drainage. Also, it could&#xD;
             influence initiation and progression of postoperative pain.&#xD;
&#xD;
          -  Greater than grade I mobility or pocket depth greater than 5mm. Need special surgical&#xD;
             and/or periodontal therapy.&#xD;
&#xD;
          -  No restorability: Hopeless tooth.&#xD;
&#xD;
          -  Vital teeth&#xD;
&#xD;
          -  Immature teeth&#xD;
&#xD;
          -  Radiographic evidence of external or internal root resorption.&#xD;
&#xD;
          -  Any criterion, not mentioned in the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nermine Hassan, Msc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <state>Manial</state>
        <zip>11553</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Singh RD, Khatter R, Bal RK, Bal CS. Intracanal medications versus placebo in reducing postoperative endodontic pain--a double-blind randomized clinical trial. Braz Dent J. 2013;24(1):25-9.</citation>
    <PMID>23657409</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 28, 2018</study_first_submitted>
  <study_first_submitted_qc>September 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 2, 2018</study_first_posted>
  <last_update_submitted>October 16, 2020</last_update_submitted>
  <last_update_submitted_qc>October 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Nermine Elsayed Abdelsalam Hassan</investigator_full_name>
    <investigator_title>Assistant Lecturer of Endodontics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dental Pulp Necrosis</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Participant data will be made available</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>It will be available after finishing the study</ipd_time_frame>
    <ipd_access_criteria>It will be uploaded on a folder on google drive to be accessed through this link</ipd_access_criteria>
    <ipd_url>https://drive.google.com/open?id=1rZXDbSgsneWDO4xGz8KGkklEHHw2YYIX</ipd_url>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://drive.google.com/open?id=1rZXDbSgsneWDO4xGz8KGkklEHHw2YYIX</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

